Announced
Completed
Synopsis
ArchiMed, a private equity firm, completed the acquisition of Cube Biotech, a biotechnology company, from Creathor Ventures, a private equity firm. Financial terms were not disclosed. “Partnering with ArchiMed will maximize Cube’s potential through better penetration of the US market, focused organic product and service expansion and the ability to leverage our knowledge and connections through acquisitions,” Barbara Maertens, Cube Co-Founder and Managing Director.
Principals
Show Details & Financials
Did you work on this deal?
Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.
By continuing, you agree to our Terms & Conditions and our Data Privacy Policy
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.